Synuclein-One Study: Skin Biopsy Detection of Phosphorylated α-Synuclein for Diagnosis of Synucleinopathies

References

• Kaufmann H , Norcliffe-KaufmannL, PalmaJAet al. Natural history of pure autonomic failure: a United States prospective cohort. Ann. Neurol.81(2), 287–297 (2017).
   PubMed Web of Science ®Google Scholar
• Savica R , GrossardtBR, BowerJH, BoeveBF, AhlskogJE, RoccaWA. Incidence of dementia with Lewy bodies and Parkinson disease dementia. JAMA Neurol.70(11), 1396–1402 (2013).
   PubMed Web of Science ®Google Scholar
• Savica R , GrossardtBR, BowerJH, AhlskogJE, RoccaWA. Incidence and pathology of synucleinopathies and tauopathies related to Parkinsonism. JAMA Neurol.70(7), 859–866 (2013).
   PubMed Web of Science ®Google Scholar
• Willis AW , SchootmanM, KungN, EvanoffBA, PerlmutterJS, RacetteBA. Predictors of survival in patients with Parkinson disease. Arch. Neurol.69(5), 601–607 (2012).
   PubMedGoogle Scholar
• Buter TC , vanden Hout A, MatthewsFE, LarsenJP, BrayneC, AarslandD. Dementia and survival in Parkinson disease: a 12-year population study. Neurology70(13), 1017–1022 (2008).
   PubMed Web of Science ®Google Scholar
• Driver JA , KurthT, BuringJE, GazianoJM, LogroscinoG. Parkinson disease and risk of mortality: a prospective comorbidity-matched cohort study. Neurology70(16 Pt 2), 1423–1430 (2008).
   PubMed Web of Science ®Google Scholar
• Forsaa EB , LarsenJP, Wentzel-LarsenT, AlvesG. What predicts mortality in Parkinson disease? A prospective population-based long-term study. Neurology75(14), 1270–1276 (2010).
   PubMed Web of Science ®Google Scholar
• Vanacore N . Epidemiological evidence on multiple system atrophy. J. Neural Transm.112(12), 1605–1612 (2005).
   PubMed Web of Science ®Google Scholar
• Marras C , BeckJC, BowerJHet al. Prevalence of Parkinson's disease across North America. NPJ Parkinsons Dis.4, 21 (2018).
   PubMed Web of Science ®Google Scholar
• Gibbons CH , FreemanR. Clinical implications of delayed orthostatic hypotension: a 10-year follow-up study. Neurology85(16), 1362–1367 (2015).
   PubMed Web of Science ®Google Scholar
• Schrag A , WenningGK, QuinnN, BenShlomo Y. Survival in multiple system atrophy. Mov. Disord.23(2), 294–296 (2007).
   Web of Science ®Google Scholar
• Beach TG , AdlerCH. Importance of low diagnostic accuracy for early Parkinson's disease. Mov. Disord.33(10), 1551–1554 (2018).
   PubMed Web of Science ®Google Scholar
• Adler CH , BeachTG, HentzJGet al. Low clinical diagnostic accuracy of early vs advanced Parkinson disease: clinicopathologic study. Neurology83(5), 406–412 (2014).
   PubMed Web of Science ®Google Scholar
• Adler CH , BeachTG, ZhangNet al. Clinical diagnostic accuracy of early/advanced Parkinson disease: updated clinicopathologic study. Neurol. Clin. Pract.11(4), e414–e421 (2021).
   PubMedGoogle Scholar
• Postuma RB , BergD, SternMet al. MDS clinical diagnostic criteria for Parkinson's disease. Mov. Disord.30(12), 1591–1601 (2015).
   PubMed Web of Science ®Google Scholar
• Stoessl AJ . Neuroimaging in Parkinson's disease: from pathology to diagnosis. Park. Relat. Disord.18(Suppl. 1), S55–S59 (2012).
   PubMedGoogle Scholar
• Godau J , HusslA, LolekhaP, StoesslAJ, SeppiK. Neuroimaging: current role in detecting pre-motor Parkinson's disease. Mov. Disord.27(5), 634–643 (2012).
   PubMed Web of Science ®Google Scholar
• Marek K , JenningsD. Can we image premotor Parkinson disease?Neurology72(Suppl. 7), S21–S26 (2009).
   PubMedGoogle Scholar
• Mollenhauer B , ZhangJ. Biochemical premotor biomarkers for Parkinson's disease. Mov. Disord.27(5), 644–650 (2012).
   PubMed Web of Science ®Google Scholar
• Mollenhauer B , LocascioJJ, Schulz-SchaefferW, Sixel-DoringF, TrenkwalderC, SchlossmacherMG. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with Parkinsonism: a cohort study. Lancet Neurol.10(3), 230–240 (2011).
   PubMed Web of Science ®Google Scholar
• Pouclet H , LebouvierT, CoronE, NeunlistM, DerkinderenP. Lewy pathology in gastric and duodenal biopsies in Parkinson's disease. Mov. Disord.27(6), 708 (2012).
   PubMed Web of Science ®Google Scholar
• Pouclet H , LebouvierT, CoronEet al. A comparison between rectal and colonic biopsies to detect Lewy pathology in Parkinson's disease. Neurobiol. Dis.45(1), 305–309 (2012).
   PubMed Web of Science ®Google Scholar
• Pouclet H , LebouvierT, CoronEet al. Analysis of colonic α-synuclein pathology in multiple system atrophy. Parkinsonism Relat. Disord.18(7), 893–895 (2012).
   PubMed Web of Science ®Google Scholar
• Lebouvier T , NeunlistM, BruleyDVet al. Colonic biopsies to assess the neuropathology of Parkinson's disease and its relationship with symptoms. PLoS ONE5(9), e12728 (2010).
   PubMed Web of Science ®Google Scholar
• Lebouvier T , ChaumetteT, DamierPet al. Pathological lesions in colonic biopsies during Parkinson's disease. Gut57(12), 1741–1743 (2008).
   PubMed Web of Science ®Google Scholar
• Shannon KM , KeshavarzianA, MutluEet al. α-Synuclein in colonic submucosa in early untreated Parkinson's disease. Mov. Disord.27(6), 709–715 (2012).
   PubMed Web of Science ®Google Scholar
• Shannon KM , KeshavarzianA, DodiyaHB, JakateS, KordowerJH. Is α-synuclein in the colon a biomarker for premotor Parkinson's disease? Evidence from 3 cases. Mov. Disord.27(6), 716–719 (2012).
   PubMed Web of Science ®Google Scholar
• Wang N , GarciaJ, FreemanR, GibbonsCH. Phosphorylated α-synuclein within cutaneous autonomic nerves of patients with Parkinson's disease: the implications of sample thickness on results. J. Histochem. Cytochem.68(10), 669–678 (2020).
   PubMed Web of Science ®Google Scholar
• Kim JY , IlligensBM, McCormickMP, WangN, GibbonsCH. α-Synuclein in skin nerve fibers as a biomarker for α-synucleinopathies. J. Clin. Neurol.15(2), 135–142 (2019).
   PubMed Web of Science ®Google Scholar
• Donadio V , DopplerK, IncensiAet al. Abnormal α-synuclein deposits in skin nerves: intra- and inter-laboratory reproducibility. Eur. J. Neurol.26(10), 1245–1251 (2019).
   PubMed Web of Science ®Google Scholar
• Donadio V . Skin nerve α-synuclein deposits in Parkinson's disease and other synucleinopathies: a review. Clin. Autonomic Res.29(6), 577–585 (2018).
   PubMed Web of Science ®Google Scholar
• Donadio V , IncensiA, DelSorbo Fet al. Skin nerve phosphorylated α-synuclein deposits in Parkinson disease with orthostatic hypotension. J. Neuropath. Exp. Neurol.77(10), 942–949 (2018).
   PubMed Web of Science ®Google Scholar
• Donadio V , WangZ, IncensiAet al. In vivo diagnosis of synucleinopathies: a comparative study of skin biopsy and RT-QuIC. Neurology96(20), e2513–e2524 (2021).
   PubMed Web of Science ®Google Scholar
• Chahine LM , BeachTG, BrummMCet al. In vivo distribution of α-synuclein in multiple tissues and biofluids in Parkinson disease. Neurology95(9), e1267–e1284 (2020).
   PubMed Web of Science ®Google Scholar
• Hughes AJ , BenShlomo Y, DanielSE, LeesAJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathologic study [published erratum appears in Neurology 1992 Jul;42(7):1436] [see comments]. Neurology42(6), 1142–1146 (1992).
   PubMedGoogle Scholar
• Gilman S , WenningGK, LowPAet al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology71(9), 670–676 (2008).
   PubMed Web of Science ®Google Scholar
• McKeith IG , BoeveBF, DicksonDWet al. Diagnosis and management of dementia with Lewy bodies: fourth consensus report of the DLB Consortium. Neurology89(1), 88–100 (2017).
   PubMed Web of Science ®Google Scholar
• Kaufmann H , Norcliffe-KaufmannL, PalmaJAet al. Natural history of pure autonomic failure: a United States prospective cohort. Ann. Neurol.81(2), 287–297 (2017).
   PubMed Web of Science ®Google Scholar
• Goetz CG . [Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS): a new scale for the evaluation of Parkinson's disease]. Rev. Neurol. (Paris)166(1), 1–4 (2010).
   PubMed Web of Science ®Google Scholar
• Goetz CG , PoeweW, RascolOet al. Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations. Mov. Disord.19(9), 1020–1028 (2004).
   PubMed Web of Science ®Google Scholar
• Gill DJ , FreshmanA, BlenderJA, RavinaB. The Montreal Cognitive Assessment as a screening tool for cognitive impairment in Parkinson's disease. Mov. Disord.23(7), 1043–1046 (2008).
   PubMed Web of Science ®Google Scholar
• Rabin R , de CharroF. EQ-5D: a measure of health status from the EuroQol Group. Ann. Med.33(5), 337–343 (2001).
   PubMed Web of Science ®Google Scholar
• Jenkinson C , FitzpatrickR, PetoV, GreenhallR, HymanN. The Parkinson's Disease Questionnaire (PDQ-39): development and validation of a Parkinson's disease summary index score. Age. Ageing26(5), 353–357 (1997).
   PubMed Web of Science ®Google Scholar
• Kaufmann H , MalamutR, Norcliffe-KaufmannL, RosaK, FreemanR. The Orthostatic Hypotension Questionnaire (OHQ): validation of a novel symptom assessment scale. Clin. Autonomic Res.22(2), 79–90 (2012).
   PubMed Web of Science ®Google Scholar
• Stiasny-Kolster K , MayerG, SchaferS, MollerJC, Heinzel-GutenbrunnerM, OertelWH. The REM sleep behavior disorder screening questionnaire – a new diagnostic instrument. Mov. Disord.22(16), 2386–2393 (2007).
   PubMed Web of Science ®Google Scholar
• Doppler K , AntelmiE, KuzkinaAet al. Consistent skin α-synuclein positivity in REM sleep behavior disorder – a two center two-to-four-year follow-up study. Park. Relat. Disord.86, 108–113 (2021).
   PubMed Web of Science ®Google Scholar
• Levine TD , BellaireB, GibbonsC, FreemanR. Cutaneous α-synuclein deposition in postural tachycardia patients. Ann. Clin. Transl. Neurol.8(4), 908–917 (2021).
   PubMed Web of Science ®Google Scholar
• Donadio V , IncensiA, RizzoGet al. A new potential biomarker for dementia with Lewy bodies: skin nerve α-synuclein deposits. Neurology89(4), 318–326 (2017).
   PubMed Web of Science ®Google Scholar
• Doppler K , JentschkeHM, SchulmeyerLet al. Dermal phospho-α-synuclein deposits confirm REM sleep behaviour disorder as prodromal Parkinson's disease. Acta Neuropathol.133(4), 535–545 (2017).
   PubMed Web of Science ®Google Scholar
• Donadio V , IncensiA, PiccininiCet al. Skin nerve misfolded α-synuclein in pure autonomic failure and Parkinson disease. Ann. Neurol.79(2), 306–316 (2016).
   PubMed Web of Science ®Google Scholar
• Haga R , SugimotoK, NishijimaHet al. Clinical utility of skin biopsy in differentiating between Parkinson's disease and multiple system atrophy. Park. Dis.2015, 167038 (2015).
   PubMed Web of Science ®Google Scholar
• Pepe M . The Statistical Evaluation of Medical Tests for Classification and Prediction.Oxford University Press, Oxford, UK (2003).
   Google Scholar
• Visanji NP , MollenhauerB, BeachTGet al. The systemic synuclein sampling study: toward a biomarker for Parkinson's disease. Biomark. Med.11(4), 359–368 (2017).
   PubMed Web of Science ®Google Scholar
• Donadio V , IncensiA, El-AgnafOet al. Skin α-synuclein deposits differ in clinical variants of synucleinopathy: an in vivo study. Sci. Rep.8(1), 14246 (2018).
   PubMed Web of Science ®Google Scholar
• Koga S , AokiN, UittiRJet al. When DLB, PD, and PSP masquerade as MSA: an autopsy study of 134 patients. Neurology85(5), 404–412 (2015).
   PubMed Web of Science ®Google Scholar
• Hughes AJ , DanielSE, BenShlomo Y, LeesAJ. The accuracy of diagnosis of Parkinsonian syndromes in a specialist movement disorder service. Brain125(Pt 4), 861–870 (2002).
   PubMed Web of Science ®Google Scholar
• Hughes AJ , DanielSE, LeesAJ. Improved accuracy of clinical diagnosis of Lewy body Parkinson's disease. Neurology57(8), 1497–1499 (2001).
   PubMed Web of Science ®Google Scholar
• Tolosa E , WenningG, PoeweW. The diagnosis of Parkinson's disease. Lancet Neurol.5(1), 75–86 (2006).
   PubMed Web of Science ®Google Scholar
• Rajput AH , RajputA. Accuracy of Parkinson disease diagnosis unchanged in 2 decades. Neurology83(5), 386–387 (2014).
   PubMed Web of Science ®Google Scholar
• Plouvier AO , OldeHartman TC, BootsLP, BloemBR, van WeelC, Lagro-JanssenAL. Time intervals in diagnosing Parkinson's disease: the patients' views. Patient Educ. Counseling98(6), 777–782 (2015).
   PubMed Web of Science ®Google Scholar
• Graebner AK , TarsyD, ShihLCet al. Clinical impact of 123I-ioflupane SPECT (DaTscan) in a movement disorder center. Neurodegener. Dis.17(1), 38–43 (2017).
   PubMed Web of Science ®Google Scholar
• Stern MB , LangA, PoeweW. Toward a redefinition of Parkinson's disease. Mov. Disord.27(1), 54–60 (2012).
   PubMed Web of Science ®Google Scholar